Tumor Necrosis Factor-α (TNFα) Stimulate Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model

被引:12
|
作者
Narasimhan, Harini [1 ]
Ferraro, Francesca [1 ]
Bleilevens, Andreas [1 ]
Weiskirchen, Ralf [2 ]
Stickeler, Elmar [1 ,3 ]
Maurer, Jochen [1 ,3 ]
机构
[1] Univ Hosp Aachen, Dept Obstet & Gynecol, D-52074 Aachen, Germany
[2] RWTH Univ Hosp Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, D-52074 Aachen, Germany
[3] Dusseldorf ABCD, Ctr Integrated Oncol CIO, Venusberg Campus 1, D-53127 Bonn, Germany
来源
BIOLOGY-BASEL | 2022年 / 11卷 / 10期
关键词
triple-negative breast cancer; cancer stem cells; TNF alpha; EMT; seed-and-soil theory; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; METASTASIS; EXPRESSION; VCAM-1; SOIL;
D O I
10.3390/biology11101481
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
TNBC represents the most aggressive breast cancer subtype. Although cancer stem cells (CSCs) are a minor fraction of all cancer cells, they are highly cancerous when compared to their non-stem counterparts, playing a major role in tumor recurrence and metastasis. Angiogenic stimuli and the tumor environment response are vital factors in cancer metastasis. However, the causes and effects of tumor angiogenesis are still poorly understood. In this study, we demonstrate TNF alpha effects on primary triple-negative breast cancer stem cells (BCSCs). TNF alpha stimulation increased the mesenchymality of BCSCs in an intermediate epithelial-to-mesenchymal transition (EMT) state, enhanced proliferation, self-renewal, and invasive capacity. TNF alpha-treatment elicited BCSC signaling on endothelial networks in vitro and increased the network forming capacity of the endothelial cells. Our findings further demonstrate that TNF alpha stimulation in BCSCs has the ability to instigate distinct cellular communication within the tumor microenvironment, inducing intra-tumoral stromal invasion. Further, TNF alpha-treatment in BCSCs induced a pre-metastatic niche through breast-liver organ crosstalk by inducing vascular cell adhesion molecule-1 (VCAM-1) enriched neovasculogenesis in the liver of tumor-bearing mice. Overall, TNF alpha is an important angiogenic target to be considered in breast cancer progression to attenuate any angiogenic response in the tumor environment that could lead to secondary organ metastasis.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells
    Oh, Sunhwa
    Kim, Hyungjoo
    Nam, KeeSoo
    Shin, Incheol
    BMB REPORTS, 2017, 50 (03) : 132 - 137
  • [32] Intratumoral Treatment with 5-Androstene-3β, 17α-Diol Reduces Tumor Size and Lung Metastasis in a Triple-Negative Experimental Model of Breast Cancer
    Ruiz Manzano, Rocio Alejandra
    Elizabeth Nava-Castro, Karen
    Isabel Palacios-Arreola, Margarita
    Hernandez-Cervantes, Rosalia
    Hugo Del Rio-Araiza, Victor
    Segovia-Mendoza, Mariana
    Perez-Torres, Armando
    Ivan Giron-Perez, Manuel
    Morales-Montor, Jorge
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [33] Inhibition of insulin-like growth factor 1 signaling synergistically enhances the tumor suppressive role of triptolide in triple-negative breast cancer cells
    Wu, Hongyan
    Sun, Ting
    Bi, Rui
    ONCOLOGY LETTERS, 2019, 18 (01) : 822 - 829
  • [34] BECN1-knockout impairs tumor growth, migration and invasion by suppressing the cell cycle and partially suppressing the epithelial-mesenchymal transition of human triple-negative breast cancer cells
    Wu, Cheng-Lin
    Zhang, Shi-Meng
    Lin, Li
    Gao, Shan-Shan
    Fu, Kai-Fei
    Liu, Xiao-Dan
    Liu, Yan
    Zhou, Li-Jun
    Zhou, Ping-Kun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (03) : 1301 - 1312
  • [35] Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
    Zhu, Wei
    Zhang, Hongwei
    Shi, Yi
    Song, Mangen
    Zhu, Bijun
    Wei, Lai
    CANCER BIOLOGY & THERAPY, 2013, 14 (11) : 1016 - 1023
  • [36] Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
    Steenbrugge, Jonas
    Breyne, Koen
    Demeyere, Kristel
    De Wever, Olivier
    Sanders, Niek N.
    Van den Broeck, Wim
    Colpaert, Cecile
    Vermeulen, Peter
    Van Laere, Steven
    Meyer, Evelyne
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [37] A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease
    Punit Kaur
    Ganachari M Nagaraja
    Hongying Zheng
    Dawit Gizachew
    Moses Galukande
    Sunil Krishnan
    Alexzander Asea
    BMC Cancer, 12
  • [38] A novel regulatory function of CDKN1A/p21 in TNFα-induced matrix metalloproteinase 9-dependent migration and invasion of triple-negative breast cancer cells
    Zaremba-Czogalla, Magdalena
    Hryniewicz-Jankowska, Anita
    Tabola, Renata
    Nienartowicz, Miroslaw
    Stach, Kamilla
    Wierzbicki, Jaroslaw
    Cirocchi, Roberto
    Ziolkowski, Piotr
    Tabaczar, Sabina
    Augoff, Katarzyna
    CELLULAR SIGNALLING, 2018, 47 : 27 - 36
  • [39] The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model
    B Yin
    Z Y Ma
    Z W Zhou
    W C Gao
    Z G Du
    Z H Zhao
    Q Q Li
    Oncogene, 2015, 34 : 761 - 770
  • [40] MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer
    Greer, Yoshimi Endo
    Gilbert, Samuel F.
    Gril, Brunilde
    Narwal, Rajesh
    Brooks, Danielle L. Peacock
    Tice, David A.
    Steeg, Patricia S.
    Lipkowitz, Stanley
    BREAST CANCER RESEARCH, 2019, 21 (1):